These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 6223940

  • 1. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR.
    J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
    Piétu G, Cherel G, Marguerie G, Meyer D.
    Nature; 1983 Jul; 308(5960):648-9. PubMed ID: 6324004
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC, Zaleski A, Nichols WL, Olson JD.
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [Abstract] [Full Text] [Related]

  • 5. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL, Kupinski JM, Castella A, Ruggeri ZM.
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC.
    Thromb Res; 1991 Jun 15; 62(6):673-84. PubMed ID: 1718052
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S, Kloczewiak M, Hawiger J.
    Proc Natl Acad Sci U S A; 1984 Aug 15; 81(15):4935-9. PubMed ID: 6087354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB, Puszkin EG, Sussman II, Mauss EA.
    J Lab Clin Med; 1990 Sep 15; 116(3):305-14. PubMed ID: 2401846
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
    Gralnick HR, Williams SB, Coller BS.
    Blood; 1984 Oct 15; 64(4):797-800. PubMed ID: 6236859
    [Abstract] [Full Text] [Related]

  • 16. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L, Mazzucato M, De Roia D, Casonato A, Federici AB, Girolami A, Ruggeri ZM.
    J Clin Invest; 1990 Sep 15; 86(3):785-92. PubMed ID: 2394830
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.